Clinical Trials Browser

NETWORK × Has results × Colony-Stimulating Factors × Clear all

NCT03794349 2026-02-18

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

Phase 2 Active not recruiting

94 enrolled 14 charts

Neuroblastoma

NCT00066365 2015-03-30

Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma

Phase 2 Completed

49 enrolled 21 charts

Neoplasm Metastasis, Sarcoma, Osteosarcoma